Green Drug Discovery: Novel Fragment Space from the Biomass-Derived Molecule Dihydrolevoglucosenone (CyreneTM)

Citations Over TimeTop 22% of 2023 papers

Abstract

Biomass-derived molecules can provide a basis for sustainable drug discovery. However, their full exploration is hampered by the dominance of millions of old-fashioned screening compounds in classical high-throughput screening (HTS) libraries frequently utilized. We propose a fragment-based drug discovery (FBDD) approach as an efficient method to navigate biomass-derived drug space. Here, we perform a proof-of-concept study with dihydrolevoglucosenone (CyreneTM), a pyrolysis product of cellulose. Diverse synthetic routes afforded a 100-membered fragment library with a diversity in functional groups appended. The library overall performs well in terms of novelty, physicochemical properties, aqueous solubility, stability, and three-dimensionality. Our study suggests that Cyrene-based fragments are a valuable green addition to the drug discovery toolbox. Our findings can help in paving the way for new hit drug candidates that are based on renewable resources.

Related Papers

• → Fragment-Based Lead Discovery and Design(2014)131 cited
• → Design of a Fragment Library that maximally represents available chemical space(2011)38 cited
• → Fragment-Based Drug Design(2010)28 cited
• → Fragment-based screening with natural products for novel anti-parasitic disease drug discovery(2019)27 cited
• → Searching for Recursively Defined Generic Chemical Patterns in Nonenumerated Fragment Spaces(2013)13 cited